Published in J Immunol Methods on January 01, 1981
Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis (1985) 1.20
Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol (1987) 1.15
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma) Br J Rheumatol (1998) 1.91
High prevalence of coeliac disease in Danish children with type I diabetes mellitus. Acta Paediatr (2001) 1.65
Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology (1993) 1.64
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit. J Clin Epidemiol (1992) 1.54
Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes (1994) 1.48
[Intra-articular glucocorticoid injections in joint diseases]. Ugeskr Laeger (1999) 1.44
Scintimetric assessment of synovitis activity during treatment with disease modifying antirheumatic drugs. Ann Rheum Dis (1988) 1.41
Organ specific antibodies in Addison's disease. Acta Med Scand Suppl (1966) 1.32
The functional domains of coagulation factor VIII:C. J Biol Chem (1986) 1.28
The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin Exp Immunol (1995) 1.25
Cellular hypersensitivity in Hashimoto's thyroiditis. Specific action of thyroid extract upon the migration of leucocytes in vitro. Acta Med Scand (1968) 1.23
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol (1999) 1.15
Organ antibodies in Sjögren's syndrome. Acta Allergol (1965) 1.09
Anti-neutrophil cytoplasm antibodies 1988. Lancet (1988) 1.06
Organ antibodies in disseminated lupus erythematosus. Acta Med Scand (1965) 1.06
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol (1998) 1.05
High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol (1994) 1.04
Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol (1998) 1.04
Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem (1996) 1.03
Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor. Scand J Rheumatol (1979) 1.03
Clinical synovitis and radiological lesions in rheumatoid arthritis. A prospective study of 25 patients during treatment with remission-inducing drugs. Scand J Rheumatol (1983) 1.03
A clinical study of 32 patients with oral discoid lupus erythematosus. Int J Oral Surg (1978) 1.02
Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease. Infect Immun (1988) 0.99
Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol (2001) 0.99
Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS (1996) 0.96
Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem (1992) 0.96
[Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA)]. Ugeskr Laeger (1986) 0.95
Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies. Acta Derm Venereol (1974) 0.95
Thyroid function, morphology and prevalence of thyroid disease in a population-based study of Danish centenarians. J Am Geriatr Soc (1999) 0.94
Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis (2001) 0.93
Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity--a methodological study. J Immunol Methods (1995) 0.93
Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol (1997) 0.92
Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinolysis (1995) 0.92
The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus. Clin Exp Immunol (1989) 0.92
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol (1998) 0.92
High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein. Biochem J (1991) 0.91
A longitudinal study of pulmonary function in Danish patients with systemic sclerosis. Clin Rheumatol (1997) 0.91
Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) (1991) 0.91
Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. J Biol Chem (1990) 0.91
Antibody to Epstein-Barr virus and cellular immunity in Hodgkin's disease and chronic lymphatic leukemia. Int J Cancer (1973) 0.90
Effect of leukocyte proteinases on tissue factor pathway inhibitor. Thromb Haemost (1992) 0.89
Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae. J Biol Chem (1993) 0.89
Screening for autoantibodies to the nucleolar U3- and Th(7-2) ribonucleoproteins in patients' sera using antisense riboprobes. J Immunol Methods (1994) 0.89
Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol (1987) 0.89
A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. Eur J Endocrinol (2003) 0.88
Absence of high-affinity calreticulin autoantibodies in patients with systemic rheumatic diseases and coeliac disease. Scand J Clin Lab Invest (2005) 0.88
Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins. Blood Coagul Fibrinolysis (1993) 0.87
Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis. Scand J Rheumatol (2013) 0.87
Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity (1991) 0.87
[Acquired immunological defects in homosexual men. A new disease entity]. Ugeskr Laeger (1982) 0.86
Circulating immune complexes in rheumatoid arthritis with extra-articular manifestations. Scand J Rheumatol (1983) 0.86
HL-A antigens in systemic lupus erythematosus. Transplant Rev (1975) 0.86
Deposits of immunoglobulins and complement in skin of patients with rheumatoid arthritis. Influence of anti-rheumatic treatment. Scand J Rheumatol (1979) 0.86
Influence of previous gold treatment and other patient variables on outcome of treatment with disease modifying anti-rheumatic drugs (DMARD) in patients with rheumatoid arthritis. Clin Rheumatol (1986) 0.86
A high-affinity folate binding protein in proximal tubule cells of human kidney. Kidney Int (1992) 0.85
Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol (1999) 0.85
Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg. Thromb Haemost (1985) 0.85
LongoVital in the treatment of Sjögren's syndrome. Clin Exp Rheumatol (1999) 0.85
Circulating immune complexes in healthy persons. Scand J Rheumatol (1982) 0.85
Intra-articular corticosteroids in arthritic disease: a guide to treatment. BioDrugs (1998) 0.84
Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review. Dan Med Bull (1984) 0.84
Pituitary-cell autoantibody diversity in sera from patients with untreated Graves' disease. Autoimmunity (1989) 0.84
Levamisole-induced nephropathy. Lancet (1978) 0.84
High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity. Arch Biochem Biophys (1999) 0.84
Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system. J Neurol Neurosurg Psychiatry (1994) 0.83
Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Diabetologia (1993) 0.83
Antibodies against double-stranded DNA in patients with connective tissue diseases. Comparison between Crithidia luciliae kinetoplast immunofluorescence test and Farr technique. Acta Med Scand (1978) 0.83
Generation of H-2-reactive T cell lines that bear the 5936 idiotype(s). J Immunol (1980) 0.83
Pharmacokinetics of full length and two-domain tissue factor pathway inhibitor in combination with heparin in rabbits. Thromb Haemost (1993) 0.83
Anti-thyroid peroxidase antibodies during pregnancy and postpartum. Relation to postpartum thyroiditis. Autoimmunity (1990) 0.83
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol (1988) 0.82
Enzyme-linked immunosorbent assay for determination of anti-mitochondrial antibodies. Acta Pathol Microbiol Immunol Scand C (1985) 0.82
Clinical manifestations in patients with autoantibodies specific for nuclear lamin proteins. Clin Immunol Immunopathol (1992) 0.82
Determination of autoantibodies to annexin XI in systemic autoimmune diseases. Lupus (2000) 0.82
Skin cauterisation marks on patients in Saudi Arabia. Lancet (1983) 0.82
High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol (2005) 0.82
Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol (1998) 0.82
Deposits of immunoglobulin and complement in psoriatic lesions. J Cutan Pathol (1980) 0.82
The lupus band test as a measure of disease activity in systemic lupus erythematosus. Arch Dermatol (1982) 0.82
Characterization of the binding between tissue factor pathway inhibitor and glycosaminoglycans. Thromb Res (1994) 0.81
Ultrasonic measurement of skin thickness in patients with systemic sclerosis. Acta Derm Venereol (2000) 0.81
Deposits of immunoglobulins and complement C3 in clinically normal skin of patients with lupus erythematosus. Acta Derm Venereol (1975) 0.81
Autoantibodies, immune complexes and HLA-D in thyrogastric autoimmunity. Tissue Antigens (1983) 0.81
Acute phase proteins and clinical synovitis activity in patients with rheumatoid arthritis. Clin Rheumatol (1987) 0.81
An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70. J Immunol Methods (1985) 0.81
Organ-specific antibodies in idiopathic panhypopituitarism, primary thyroid and adrenal insufficiency. Acta Med Scand (1969) 0.80
Characterization of a high-affinity folate receptor in normal and malignant human testicular tissue. Biosci Rep (1999) 0.80
Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Clinical, biochemical, radiological and scintigraphic studies. Dan Med Bull (1984) 0.79
Abnormal vitamin D3 metabolism in patients with primary Sjögren's syndrome. Ann Rheum Dis (1990) 0.79